Skip to main content
NACFC 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF
Livestreamed Session
Livestreamed Session
Recorded Session
Recorded Session
Session is Ticketed (Must Register for Session through Registration)
Session is Ticketed (Must Register for Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees
Session Feedback

NTR

CLIN
Session Type: Thematic Poster Session

TPS06--Nourishing Horizons: Innovations in GI, Endocrine, & Nutrition in CF | Theater A Exhibit Hall

Saturday, October 25, 2025
8:15 AM - 9:45 AM PDT
Location:Theater A Exhibit Hall

This session will focus on innovations in CF care in GI, endocrine, and nutrition arenas. Abstracts will be available for viewing in poster form, followed by a moderated discussion of each study.  Principals of the studies selected for presentation will be available to present their work and answer questions.

Learning Objectives:

  • Attendees will be able to list advances in gastroenterology care for the cystic fibrosis population
  • Attendees will be able to describe changes in the standard of care for endocrine complications of cystic fibrosis
  • Attendees will be able to enumerate the changes in nutrition care since the advent of modulators

Presentations:

  • 8:15 AM - 9:45 AM PDT
    TPS06.1- Probiotics and the EARly Life effects on intestinal bacteria and inflammation in children with CF (PEARL-CF) Study

    Speaker: Josie van Dorst

  • 8:15 AM - 9:45 AM PDT
    TPS06.2- Factors that increase likelihood of 30-day hospital readmissions in patients with CF: A national readmissions database study

    Speaker: Tanushree Laud, MD – Rutgers Robert Wood Johnson Medical School

  • 8:15 AM - 9:45 AM PDT
    TPS06.3- Fibrosis biomarkers in pediatric CF liver disease: A useful tool for screening

    Speaker: Treiy Tinich, Master of Science, Global Health – UMKC School of Medicine, University of Texas Southwestern/Children’s Health

  • 8:15 AM - 9:45 AM PDT
    TPS06.4- Burden of digestive system complications in the CF community

    Speaker: Leah Richey, MPH – Cystic Fibrosis Foundation

  • 8:15 AM - 9:45 AM PDT
    TPS06.5- Dynamic time warping analysis of continuous glucose monitoring reveals significant dysglycemia that is underestimated by oral glucose tolerance test classification

    Speaker: Jiafeng Song, M.Sc. – Duke University

  • 8:15 AM - 9:45 AM PDT
    TPS06.6- ANG003, a non-porcine pancreatic enzyme replacement therapy, provides significantly higher enzymatic activity than porcine products over the range of gastrointestinal pHs and USP monograph pH 9

    Speaker: David J. Brown, BS – Anagram Therapeutics

  • 8:15 AM - 9:45 AM PDT
    TPS06.7- Dietary linoleic acid is associated with increased adiposity in adults with CF not taking CFTR modulators

    Speaker: Matthea E. Schor, n/a – Emory University

  • 8:15 AM - 9:45 AM PDT
    TPS06.8- Efficacy and safety of GLP-1 agonist therapy in overweight and obese subjects with CF-related diabetes: A pilot study

    Speaker: Amir Moheet, MD – University of Minnesota

  • 8:15 AM - 9:45 AM PDT
    TPS06.9- Using RELiZORB® (Immbolized Lipase Cartridge) for Surgical Cystic Fibrosis Infants in the Neonatal Intensive Care Unit

    Speaker: Rebecca Wilhelm, MS, RD, LD, CNSC – CCHMC

  • 8:15 AM - 9:45 AM PDT
    TPS06.10- Comparison of continuous glucose monitoring to the oral glucose tolerance test as a screen for CF-related diabetes

    Speaker: Michelle McDonagh – Froedtert Health